Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia
06 nov. 2023 13h07 HE
|
Sobi, Inc.
Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia